FDMT · 4D Molecular Therapeutics, Inc.

NasdaqHealthcareBiotechnology

4d Molecular Therapeutics Inc Is Biotechnology Company Advancing Durable And Disease-Targeted Therapeutics With Potential To Transform Treatment Paradigms And Provide Unprecedented Benefits To Patients. Companies Focus Is On Advancing 4d-150 For Wet Age-Related Macular Degeneration (Wet Amd) And Diabetic Macular Edema (Dme) Through Late-Stage Studies. It Has Built A Portfolio Of Gene Therapy Product Candidates Focused On Three Therapeutic Areas: Ophthalmology (Intravitreal Vector) Includes 4d-150, 4d-710 And 4d-175; Cardiology (Intravenous Vector) Includes 4d-710, 4d-725, And Pulmonology (Aerosol Vector).

HealthcareNasdaqUS

FLOAT

53.3M

FREE FLOAT %

97%

SHARES O/S

55.2M

MARKET CAP

$596.6M

EXCHANGE

Nasdaq

COUNTRY

FDMT Catalyst History

No catalysts recorded for FDMT yet

Day Trader Sniper hasn't classified a publishable catalyst for FDMT yet. New events appear here as they're scored.

Be early on the next FDMT spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

FDMT · 4D Molecular Therapeutics, Inc.

FDMT Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.